Tyrosine Kinase 2 Inhibitor
DBCAT005872Therapeutic category
A DrugBank category of 2 drugs. 2 of them are approved.
What you can answer from here — as of September 26, 2023
Which targets do Tyrosine Kinase 2 Inhibitor share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account